Folic acid |
Folate-modified polyplex |
By combining folic acid with PEI, these polyplex would target to caveolae in Hela cells and enhance the gene delivery efficacy |
Tumor cells |
Bypasses lysosomes and helps gene delivery |
65 |
Cholesterol |
Cholesterol-modified PLGA nanoparticles encapsulating curcumin |
Tumor targeting and antitumor efficacy are enhanced by caveolin-mediated endocytosis |
Tumor cells |
Bypass lysosomes and increase antitumor efficacy |
67 |
Sphingolipid |
Sphingolipid-decorated self-micellizing antitumor nanoparticles |
High affinity between sphingolipid with caveolae enhances nanoparticles to actively target tumor cells without ligands modification |
Tumor cells |
Increases targeting ability and bypass lysosomes |
68 |
Lipophilic polyelectrolytes |
Polyelectrolytes with aromatic sulfonic acid backbone |
Negatively charged aromatic sulfonic backbone modified polyelectrolytes would be selectively internalized by endothelial cells which are highly express caveolin-1 compared with epithelial cells |
Endothelial cells |
Transcytosis |
69 |
Albumin |
Albumin-bound paclitaxel |
Increases the binding with endothelial cells in blood vessels and helps transport to tumor tissues for drug accumulation. |
Endothelial cells |
Transcytosis |
70, 71, 72
|
Albumin-coated gold nanoparticles |
20 nm-sized albumin-coated gold NPs bind to gp60 to internalize into cells via caveolin-mediated pathway |
Endothelial cells |
Transcytosis |
73,74
|
Albumin-modified PS nanoparticles |
Albumin-modified PS nanoparticles have highest co-localization with caveolin-1 in endothelial cells and pass through cells |
Endothelial cells |
Transcytosis |
75 |
Albumin-modified polyplex |
Albumin-modified polyplex delivering siRNA enters cells via caveolin-mediated endocytosis and increases the silencing effect |
Tumor cells |
Bypasses lysosomes and increases gene transduction efficacy |
76 |
Liposomes |
Liposomes-loaded paclitaxel |
By caveolae-targeting transcytosis in VEGFR2-inhibited blood vessels, the accumulation of paclitaxel to tumor tissues is enhanced by loading paclitaxel into liposomes |
Endothelial cells |
Transcytosis |
77 |
Solid lipid nanoparticles |
SLN-encapsulated paclitaxel |
The overexpression of caveolin-1 in drug-resistant tumor cells helps SLN/paclitaxel internalization by caveolin-mediated endocytosis |
Tumor cells |
Bypasses lysosomes and increases drug response |
78 |